Centro de Imagem Diagnosticos SA
BOVESPA:AALR3

Watchlist Manager
Centro de Imagem Diagnosticos SA Logo
Centro de Imagem Diagnosticos SA
BOVESPA:AALR3
Watchlist
Price: 8.55 BRL -2.84% Market Closed
Market Cap: 1B BRL
Have any thoughts about
Centro de Imagem Diagnosticos SA?
Write Note
Section:
 

Relative Value

The Relative Value of one AALR3 stock under the Base Case scenario is 16.05 BRL. Compared to the current market price of 8.55 BRL, Centro de Imagem Diagnosticos SA is Undervalued by 47%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AALR3 Relative Value
Base Case
16.05 BRL
Undervaluation 47%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.9
P/S
P/S
Price to Sales
0.9
vs History
53
vs Industry
62
Median 3Y
1.7
Median 5Y
1.5
Industry
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-9.8
Median 5Y
-9.8
Industry
23.2
More Details
6
P/OCF
P/OCF
Price to OCF
6
vs History
46
vs Industry
17
Median 3Y
12.9
Median 5Y
10.2
Industry
14.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-3
Median 5Y
-2.2
Industry
20.1
More Details
0.9
P/B
P/B
Price to Book Value
0.9
vs History
44
vs Industry
51
Median 3Y
1.7
Median 5Y
1.3
Industry
2.2
More Details
1.3
EV/S
EV/S
Enterprise Value to Sales
1.3
vs History
47
vs Industry
51
Median 3Y
2.2
Median 5Y
1.9
Industry
2.4
More Details
4.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
4.5
vs History
63
vs Industry
35
Median 3Y
7
Median 5Y
7.9
Industry
5
More Details
12.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
12.1
vs History
36
vs Industry
16
Median 3Y
17.2
Median 5Y
15.2
Industry
12.8
More Details
41.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
41.8
vs History
22
vs Industry
1
Median 3Y
47.9
Median 5Y
20.1
Industry
17.2
More Details
9.5
EV/OCF
EV/OCF
Enterprise Value to OCF
9.5
vs History
49
vs Industry
11
Median 3Y
16.4
Median 5Y
13.7
Industry
14
More Details
18.4
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
18.4
vs History
46
vs Industry
2
Median 3Y
26.1
Median 5Y
24.1
Industry
18.2
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
44
vs Industry
60
Median 3Y
1.1
Median 5Y
0.9
Industry
1.9
More Details

Multiples Across Competitors

AALR3 Competitors Multiples
Centro de Imagem Diagnosticos SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
BR
Centro de Imagem Diagnosticos SA
BOVESPA:AALR3
1B BRL 0.9 -4.6 12.1 41.8
US
Cigna Group
XMUN:CGN
75B EUR 0.3 25.7 8 10.4
US
Cigna Corp
NYSE:CI
77.2B USD 0.3 25.4 8 10.3
US
CVS Health Corp
NYSE:CVS
56.5B USD 0.2 11.3 9.6 9.6
DE
Fresenius Medical Care AG
XMUN:FME
25.9B EUR 1.3 39.2 10.7 23.1
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.9B EUR 0.9 -49.3 9.3 19
US
Laboratory Corporation of America Holdings
NYSE:LH
19.2B USD 1.5 44.1 13.2 20.3
US
R1 RCM Inc
NASDAQ:RCM
17.7B USD 7.2 -289.7 38.3 99.1
US
Quest Diagnostics Inc
NYSE:DGX
16.9B USD 1.8 20.2 12.2 16.5
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13B EUR 0.7 19.7 6.6 14.3
US
DaVita Inc
NYSE:DVA
12.4B USD 1 14.9 7.8 10.9
P/E Multiple
Earnings Growth PEG
BR
Centro de Imagem Diagnosticos SA
BOVESPA:AALR3
Average P/E: 25.1
Negative Multiple: -4.6 		N/A N/A
US
C
Cigna Group
XMUN:CGN
25.7
25%
1
US
Cigna Corp
NYSE:CI
25.4
25%
1
US
CVS Health Corp
NYSE:CVS
11.3
3%
3.8
DE
Fresenius Medical Care AG
XMUN:FME
39.2
31%
1.3
DE
Fresenius SE & Co KGaA
XETRA:FRE
Negative Multiple: -49.3 N/A N/A
US
Laboratory Corporation of America Holdings
NYSE:LH
44.1
54%
0.8
US
R1 RCM Inc
NASDAQ:RCM
Negative Multiple: -289.7
253%
N/A
US
Quest Diagnostics Inc
NYSE:DGX
20.2
12%
1.7
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
19.7
31%
0.6
US
DaVita Inc
NYSE:DVA
14.9
17%
0.9

See Also

Summary
AALR3 intrinsic value, competitors valuation, and company profile.
DCF Valuation
AALR3 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AALR3 stock valuation using valuation multiples.
Wall Street Estimates
AALR3 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AALR3 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 212,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.